Publication|Articles|November 1, 2024

Evidence-Based Oncology

  • November 2024
  • Volume 30
  • Issue 12

Table Multiple Myeloma Trials November 2024

Key Takeaways

TABLE. Multiple Myeloma: Enrollment of Black Patients in Trials Required for Initial FDA Approval

TABLE

Articles in this issue

about 1 year ago

To Improve Clinical Trial Equity in Multiple Myeloma, Just Ask

about 1 year ago

Collaborating for Cancer Care Equity: Community and Academic Insights

about 1 year ago

Elevating Value in Cancer Care With Innovations, Accessibility, Equity

about 1 year ago

Innovating Cancer Care Through Equity and AI: Vanderbilt’s Vision

about 1 year ago

Advancing Equitable Access to Elevate Value-Based Cancer Care

about 1 year ago

Putting Patients First by Extending the Reach of World-Class Care

about 1 year ago

As Myeloma Trials Tackle Frontline Treatment, Where Are the Black Patients?

over 1 year ago

SPOTLIGHT: What the Approval of Isatuximab Plus VRd Means to Multiple Myeloma Care

over 1 year ago

NCCN Guidelines for MPN Reflect New Drugs, Focus on Clinical Trials

over 1 year ago

CRC Screening Increases in Patients Aged 45 to 49 After USPSTF Recommendation

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs
Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

View more
Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care
AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

View more
Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo
Alt TextAlt Text